Notes / Company Sai Parenteral's Ltd. SAIPARENT BSE 544742 ISIN INE0H9F01037 Pharmaceuticals Fundamentals Market cap₹2,150 cr P/E150.80× ROE15.16% Debt / equity1.00 52-week range 400.00 — 526.30 Research on Tijori Finance The timeline — 1 note on Sai Parenteral's Ltd. May 2026 23 May 26 · 8:14 PM IST Brief Brief · Earnings Sai Parenterals targets ₹750 crore revenue after Noumed integration The pharmaceutical firm reported a 167% jump in quarterly revenue to ₹198 crore. This follows the first full-year consolidation of its Australian subsidiary. Verify on exchange BSE filings for SAIPARENT NSE filings for SAIPARENT Tijori Finance company page